6 completed. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 3 | Completed 3 |
Follow Scorpion Stings: new trials by email Literature Review of Scorpion Stings trials Research Report on Scorpion Stings
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism Traditional scorpion antivenom regimen, Serial dose of scorpion antivenom regimen - Centruroides Envenomation | Phase 2 / Phase 3 | Completed | Selene Guadalupe Huerta Olvera | 56 | 2024-06-15 | 2025-12-17 |
| Compare Two Anti-Scorpion Venom Serum In Children Anti-scorpion venom serum Birmex, Anti-scorpion venom serum Alacramyn - Scorpion Sting | Phase 3 | Completed | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. | 120 | 2011-08-01 | 2013-02-07 |
| AScVS and/ or Prazosin for Scorpion Envenomation Antiscorpion venom serum(AScVS)., T.Prazosin, AScVS + Prazosin - Scorpion Envenomation | Phase 3 | Completed | Haffkine Bio-Pharmaceutical Corporation Ltd. | 81 | 2006-09-01 | 2008-09-16 |
| Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation Antivenin Centruroides (scorpion) F(ab)2 Anascorp™ - Scorpion Sting Envenomation | Phase 2 / Phase 3 | Completed | Instituto Bioclon S.A. de C.V. | 1426 | 2005-05-01 | 2011-02-23 |
| Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients Antivenin Centruroides (scorpion) equine immune F(ab)2, Placebo - Scorpion Sting Envenomation | Phase 2 / Phase 3 | Completed | Instituto Bioclon S.A. de C.V. | 15 | 2004-05-01 | 2011-06-02 |
| Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation Anascorp - Scorpion Sting | Phase 3 | Completed | Instituto Bioclon S.A. de C.V. | 50 | 2004-04-01 | 2016-03-22 |
Bites and Stings (6) · Chemically-Induced Disorders (6) · Poisoning (6) · Wounds and Injuries (6)
Prazosin (1)
Instituto Bioclon S.A. de C.V. (3) · Haffkine Bio-Pharmaceutical Corporation Ltd. (1) · Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. (1) · Selene Guadalupe Huerta Olvera (1)
United States (3) · Mexico (2) · India (1)
Alejandro Alagon, PhD (2) · Dr Vivek S Natu, M.S. (1) · Dr. Geeta Kadam, M.B.B.S. (1) · Dr. Nirmala Rege, M.D. (1) · Dr. Rajesh Kushte, MBBSDCH (1) · Dr. Ravindra Bapat, M.S. (1) · Dr. Sanjeev Sane, MBBS DCH (1) · Dr. Santosh Kamerkar, M.S (1) · Dr. Sunil Thatte, M.D. (1) · Dr. Uchil Dinesh, Ph.D. (1) · Dr. Vidya Kamble, M.B.B.S. (1) · Dr. Vikas Natu, MBBS DCH (1) · Leslie Boyer, M.D (1) · Leslie Boyer, MD (1)